ESI Table 1 -Specifications of the mask designs of the deterministic lateral displacement devices. The device critical separation size (Dc = critical diameter) was calculated using the formula empirically derived by Davis 1 (Dc = 1.4G • N -0.48 )
In a) -Device 1, note the unitary sample channel (i) that allows hydrodynamic focusing of the sample at the device entrance by adjacent sheath flow introduced at either side (ii). The sample:sheath ratio in device 1 was 1:25, which led to significant sample dilution and reduced throughput. In b) -Device 2, note the use of a mirrored micropillar array (ii) that allows creating a central cell-free stream when using a sheathless device to increase throughput. In c) -Device 3, note the combination of sheath flow (i) and a mirrored micropillar array (ii) to achieve sorting with high resolution and low sample dilution (sample:sheath, 1:1).
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Device design and fabrication

Edge correction
A parabolic flow profile occurs between the micropost arrays in DLD and is key for efficient particle separation. However, this profile holds only for infinitely wide arrays and becomes perturbed at the interface between the array and the sidewall flow significantly degrading sorting efficiency. To minimise this effect, Inglis 2 proposed a method for edge correction that assures that 1/N th of the total fluid will flow over each post at all times, with N the period of the array. The solution was to adjust the gap size between the pillar rows closest to the walls of the device. The gap between each post and the wall of the zigzagging and the bumping sides is given by Equations 1 and 2 respectively, where n is the column number in a displacement array assuming values from 1 to N, G the gap size and ψ the tangent of the particle migration angle. An example of edge correction calculations in shown in ESI Table 2 . Gap before bumping wall
Hydraulic resistance calculations
Whenever different sections of the DLD devices were connected by rectangular channels with varying lengths, the channel width was adjusted accordingly to guarantee an identical hydraulic resistance across the device span, which was estimated for each channel using equation 3, 3 where w, h and L are the channel dimensions and η the fluid viscosity. Computational fluid dynamics simulations in COMSOL Multiphysics 4.3 (COMSOL AB, Stockholm, Sweden) were conducted to verify that both flow and particle profiles were preserved (ESI Figure 2 a-c). These steps were crucial to assure that particles maintained their relative positions before and after the connecting sections channels. Detailed microfabrication methods Briefly, wafers were cleaned in fuming nitric acid, dehydrated overnight at 210 ℃ and spin-coated (3,000 rpm, 30 s) with TI Prime to promote adhesion of the photo-resist. An SU-8 formulation was chosen according to the projected feature height, spin-coated for 30 s and soft baked before UV exposure using an EVG® 620T mask aligner (EV Group, St. Florian am Inn, Austria). Wafers were finally post-exposure baked, developed in EC solvent and hard baked. The feature height was verified using a KLA-Tencor surface profiler (CA, USA). Details of the process specifications are listed in ESI, Table 3 . The silicon master moulds were pre-treated with a layer of hydrophobic 1H,1H,2H,2H-per-fluorooctyl-trichlorosilane to facilitate de-moulding. Sylgard® 184 PDMS elastomer was prepared by mixing the elastomer with curing agent (10:1, w/w), degassed and cured over the mould at 80 ℃ for one hour. Inlets/outlets were opened using a 1.5 mm biopsy punch (Kai Europe GmbH, Solingen, Germany). The PDMS stamps were oxygen plasma bonded to PDMS-coated glass-slides using a Femto Plasma Asher (Diener electronic GmbH + Co. KG, Germany). 
ESI
Device operation
ESI Figure 3 -DLD device operation in a sterile environment (laminar flow hood). A portable microscope built in-house was used to monitor the flow stability.
Cell Culture
Cells were maintained in media supplemented with 10 % foetal calf serum (FCS) and 100 U·mL -1 penicillin and 100 μg·mL -1 streptomycin (1 % Pen/Strep). This is referred to as complete media. Otherwise, it is indicated as plain media. Cells were maintained in a humidified chamber at 37 ℃ and 5 % CO2.
MG-63
MG-63 human osteosarcoma cells (passages 27 to 30) were obtained from the European Collection of Authenticated Cell Cultures (ECACC, UK) and cultured in complete DMEM. The culture media was replenished every 2-3 days and the cells were routinely sub-cultured assuring a maximum confluence of 70% and re-plated at a cell seeding density of 2-4 x 10 4 cells·cm -2 .
GFP + MG-63
GFP + MG-63 cells were established in previous work by transduction with a retroviral pMX-GFP vector (Cell Biolabs Inc., VPK-302) 4 containing a green fluorescent protein (GFP) insert and using polybrene as a transduction enhancer. 4 Culture of GFP + MG-63 cells was under the same conditions as non-transfected MG-63.
Xavier et al. 2018 Label-free enrichment of primary human bone marrow progenitor cells using deterministic lateral displacement -Electronic Supplementary Information HL-60 HL-60, human peripheral blood promyelocytic leukaemia cells were obtained from the European Collection of Authenticated Cell Cultures (ECACC, UK) and cultured in complete RPMI-1640 media. The cells were split every other day to a concentration of 2 x 10 5 cells·mL -1 .
Flow cytometry
HL-60 labelling with CellTracker™ Deep Red Dye
HL-60 were washed in PBS, suspended in 1 μM CellTracker™ deep red dye (C34565 from Invitrogen™) in pre-warmed plain RPMI and incubated for 45 minutes in a humidified chamber at 37 ℃ and 5 % CO2. After incubation, the dye was removed by centrifugation and the cells washed twice with PBS before analysis.
Skeletal stem cell labelling with CellTracker™ Green CMFDA Dye
Adhered SSCs were washed with PBS, pre-treated with collagenase IV (200 μg·mL -1 ) in plain α-MEM for 40 to 60 min. and incubated with 10 μM CellTracker™ green CMFDA (C7025 from Invitrogen™) in pre-warmed plain α-MEM for 45 minutes. After incubation, the dye was removed and the cells were further cultured in complete α-MEM for 60 minutes to encourage the conversion of the chloromethyl group into cell-impermeable products by cytosolic esterases. Cells were then washed with PBS and lifted as detailed above.
White blood cell labelling of CD45
WBCs from whole blood were fluorescently labelled for CD45 by incubation with an APC-conjugated anti-human CD45 antibody (Miltenyi Biotec 130-098-143) for 20 minutes under agitation, in the dark. RBC lysis was performed as in the main text. 
Statistical Analyses ESI
Materials
BioWhittaker® Dulbecco's modified Eagle medium with glucose and L-glutamine (DMEM), alpha minimum essential medium with deoxyribonucleotides, ribonucleotides and ultra-glutamine (α-MEM), RPMI-1640, Dulbecco's phosphate buffered saline (PBS), foetal calf serum (FCS) and trypsin/EDTA with glucose were obtained from Lonza (Basel, Switzerland). Penicillin-streptomycin 100x, AB human serum, collagenase IV, ethylenediamine tetra-acetic acid (EDTA), crystal violet, Ficoll® PM400, Trichloro(1H,1H,2H,2H-perfluorooctyl)silane and Pluronic® F-127 were purchased from Sigma-Aldrich (St. Louis, MO, USA). Non-deformable polystyrene beads for size-based sorting were from Polysciences Europe GmbH (Germany). Bovine serum albumin (BSA) was obtained from GE Healthcare (Chicago, IL, USA). Lymphoprep™ was bought from Stem Cell Technologies (Vancouver, Canada). Anti-mouse IgM microbeads, LS MACS™ columns and the QuadroMACS™ separator were purchased from Miltenyi Biotec (Bergisch Gladbach, Germany). TI Prime, SU-8 50 and SU-8 3025 were from Microchem Corp. (Westborough, MA, USA). The EC solvent was from Dow® Microposit® (MicroResist Technology GmbH, Germany). S-Monovette® 9NC tri-sodium citrate tubes were obtained from Sarstedt (Nümbrecht, Germany) and Sylgard® 184 polydimethylsiloxane (PDMS) was purchased from VWR (Darmstadt, Germany). All reagents were used as received and according to the manufacturer's recommendations. Figure 7 -Forward (FSC-A) and side (SSC-A) scatter distributions of CD45-labelled WBCs (red) and SSCs (green) labelled with CellTracker™ green, unsorted and collected at the larger-cell outlet after label-free sorting by DLD. Contour levels were set at 5 %. Interestingly, at 15 µL·min -1 it was the smallest fraction of WBCs (possibly lymphocytes) that appeared in the larger-cell outlet. With increasing flow rate, the size distribution spread to gradually include larger cells but still excluded the largest WBCs. This led to the conclusion that cell deformation resulted in the smallest WBC sub-populations changing their effective size to diameters below the DC of section 1 (5.3 µm). This effect was exacerbated at highest flow rates, when cell deformation became more significant.
Device 3 3.3.1. Enrichment of primary human bone marrow mononuclear cells
ESI Figure 8 -Colony forming units-fibroblastic (CFU-F), counterstained with crystal violet, growing in wells of a 6-well plate. Human bone marrow mononuclear cells were sorted by DLD at , collected from the smaller-cell and larger-cell outlets and plated at a cell seeding density of 10,000 cells·cm -2 . Cells collected at the larger-cell outlet appear to display a higher capacity to form clonogenic cultures.
